Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Current Period Unaudited)

v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Cash and cash equivalents $ 3,311,000 $ 7,609,000
Accounts receivable 6,240,000 8,287,000
Prepaid expense and other current assets 1,134,000 862,000
Total current assets 10,685,000 16,758,000
Property and Equipment, net 53,000 70,000
Intangible assets, net 5,603,000 6,636,000
Goodwill 1,864,000 1,864,000
Other receivable, noncurrent 395,000 0
Total assets 18,600,000 25,328,000
Accounts payable 7,110,000 10,420,000
Accrued contingent consideration 2,017,000 1,812,000
Contract liabilities 334,000 339,000
Secured loan – SLR Facility 370,000 800,000
Total current liabilities 9,831,000 13,371,000
Accrued contingent consideration – long term 449,000 396,000
Warrant liability 2,332,000 1,571,000
Total liabilities 12,612,000 15,338,000
Commitments and Contingencies  
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; 22,078 and 23,656 and shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively. 0 0
Common stock, par value $0.001 per share; 400,000,000 shares authorized; 5,982,912 and 4,774,116 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively. 83,000 81,000
Additional paid-in capital 260,183,000 258,923,000
Accumulated deficit (254,278,000) (249,014,000)
Total stockholders’ equity 5,988,000 9,990,000
Total liabilities and stockholders’ equity $ 18,600,000 $ 25,328,000